v3.25.3
SEGMENT AND GEOGRAPHIC DATA
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC DATA

NOTE 10— SEGMENT AND GEOGRAPHIC DATA

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of operating segments, has been identified as the Chief Executive Officer (the “CODM”). The Company conducts its business through two reportable segments: Dental and Medical. These segments offer different products and services to various customer base. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and operating income (loss). Certain reclassifications have been made to the 2025 unaudited condensed consolidated financial statements to conform to the 2024 unaudited condensed consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously reported.

 

The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate Services” below and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance.

 

 

The following tables present information about our reportable and operating segments for the three and nine months ended September 30, 2025, and 2024:

 

   Corporate   Dental   Medical   Grand Total 
   Three Months ending September 30, 2025 
   Corporate   Dental   Medical   Grand Total 
Product sales, net  $-   $2,318,993   $41,124   $2,360,117 
Cost of products sold   -    718,481    766    719,247 
Gross Margin   -    1,600,512    40,358    1,640,870 
                     
Salaries & employee benefits   387,591    440,807    170,429    998,827 
Stock compensation    363,084    -    -    363,084 
Royalties   -    116,540    2,065    118,605 
Marketing   21,321    32,980    9,249    63,550 
Rent & occupancy costs   22,805    12,521    7,826    43,152 
Consultants and professional services fees   550,229    37,633    65,633    653,495 
Insurance   40,907    45,051    39,969    125,927 
Warehousing expense   2,885    107,564    7,465    117,914 
Regulatory expense   42,446    18,192    3,862    64,500 
Travel expense   23,364    4,518    9,178    37,060 
Research and development expense   -    15,401    825    16,226 
Depreciation and amortization    20,104    -    -    20,104 
Other Segments items   76,116    75,913    868    152,897 
Total operating expenses   1,550,852    907,120    317,369    2,775,341 
 Operating income (loss)  $(1,550,852)  $693,392   $(277,011)  $(1,134,471)

 

   Corporate   Dental   Medical   Grand Total 
   Three Months ending September 30, 2024 
   Corporate   Dental   Medical   Grand Total 
Product sales, net  $-   $2,468,205   $45,600   $2,513,805 
Cost of products sold   -    674,164    3,421    677,585 
Gross Margin   -    1,794,041    42,179    1,836,220 
                     
Salaries & employee benefits   427,416    396,533    200,992    1,024,941 
Stock compensation    484,077    -    -    484,077 
Royalties   -    124,178    2,370    126,548 
Marketing   20,348    80,316    13,943    114,607 
Rent & occupancy costs   15,501    12,243    7,652    35,396 
Consultants and professional services fees   520,204    42,850    107,170    670,224 
Insurance   140,021    -    -    140,021 
Warehousing expense   3,615    106,723    7,459    117,797 
Regulatory expense   91,881    10,977    7,964    110,822 
Travel expense   11,425    17,492    25,141    54,058 
Research and development expense       232,056    -    232,056 
Depreciation and amortization    8,574            8,574 
Other Segments items   91,425    92,355    2,498    186,278 
Total operating expenses   1,814,487    1,115,723    375,189    3,305,399 
 Operating income (loss)  $(1,814,487)  $

678,318

   $(333,010)  $(1,469,179)

 

 

   Corporate   Dental   Medical   Grand Total 
   Nine Months ending September 30, 2025 
   Corporate   Dental   Medical   Grand Total 
Product sales, net  $-   $6,791,353   $124,650   $6,916,003 
Cost of products sold   -    2,008,242    1,850    2,010,092 
Gross Margin   -    4,783,111    122,800    4,905,911 
                     
Salaries & employee benefits   711,476    1,322,768    569,276    2,603,520 
Stock compensation    853,550    -    -    853,550 
Royalties   -    344,642    6,233    350,875 
Marketing   35,738    164,656    53,476    253,870 
Rent & occupancy costs   57,216    38,894    24,309    120,419 
Consultants and professional services fees   2,333,311    178,428    326,992    2,838,731 
Insurance   124,282    139,273    122,483    386,038 
Warehousing expense   9,123    326,564    33,426    369,113 
Regulatory expense   371,267    101,186    9,261    481,714 
Travel expense   39,843    62,056    74,470    176,369 
Research and development expense   -    427,297    9,838    437,135 
Depreciation and amortization    59,040    -    -    59,040 
Other Segments items   229,071    349,148    14,273    592,492 
Total operating expenses   4,823,917    3,454,912    1,244,037    9,522,866 
 Operating income (loss)  $(4,823,917)  $1,328,199   $(1,121,237)  $(4,616,955)

 

   Corporate   Dental   Medical   Grand Total 
   Nine Months ending September 30, 2024 
   Corporate   Dental   Medical   Grand Total 
Product sales, net  $-   $6,544,394   $72,020   $6,616,414 
Cost of products sold   -    1,685,119    7,769    1,692,888 
Gross Margin   -    4,859,275    64,251    4,923,526 
                     
Salaries & employee benefits   985,315    1,150,945    599,802    2,736,062 
Stock compensation   1,003,192    -    2,078    1,005,270 
Royalties   -    333,499    3,691    337,190 
Marketing   68,694    297,753    31,660    398,107 
Rent & occupancy costs   51,300    36,729    22,956    110,985 
Consultants and professional services fees   1,642,583    126,902    593,932    2,363,417 
Insurance   343,903    44,913    33,598    422,414 
Warehousing expense   9,769    333,426    27,331    370,526 
Regulatory expense   329,698    16,040    14,296    360,034 
Travel expense   39,051    66,706    72,295    178,052 
Research and development expense   -    638,226    3,009    641,235 
Depreciation and amortization    28,735    -    -    28,735 
Other Segments items   388,639    288,116    9,414    686,169 
Total operating expenses   4,890,879    3,333,255    1,414,062    9,638,196 
 Operating income (loss)  $(4,890,879)  $1,526,020   $(1,349,811)  $(4,714,670)

 

   September 30, 2025 
   Dental   Medical   Corporate   Total 
Total Assets  $6,504,045   $376,246   $1,605,732   $8,486,023 
    6,504,045    376,246    1,605,732    8,486,023 

 

   December 31, 2024 
   Dental   Medical   Corporate   Total 
Total Assets  $5,359,734   $444,513   $3,992,825   $9,797,072 
    5,359,734    444,513    3,992,825    9,797,072